Voyager Therapeutics Inc (NASDAQ:VYGR)
| 7.27 Delayed Data As of 3:59pm ET |  +0.24 / +3.41%Today’s Change | 5.27 Today|||52-Week Range 14.34 | +19.18% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -29.7M | -40.2M | -70.7M | -88.3M | |
| Depreciation | 600.0K | 612.0K | 1.6M | 2.1M | ||
| Total Other Cash Flow | 14.0M | 8.9M | 9.4M | 14.6M | ||
| Funds From Operations | -15.1M | -30.7M | -59.7M | -71.6M | ||
| Funds From/For Other Operating Expenses | -56.4M | 11.8M | 1.6M | -55.7M | ||
| Net Cash Flow - Operating Activities | 41.3M | -42.5M | -61.4M | -15.9M | ||
| Investing | Increase In Investments | -220.4M | -112.8M | -147.3M | -333.2M | |
| Decrease In Investments | 26.7M | 165.1M | 147.6M | 364.0M | ||
| Capital Expenditures | -1.0M | -5.0M | -4.0M | -4.3M | ||
| Net Cash Flow Investing | -194.8M | 47.3M | -3.7M | 26.5M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 104.8M | 514.0K | 59.9M | 4.7M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | -- | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | -- | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 73.0M | 0.00 | 0.00 | 0.00 | ||
| Other Uses - Financing | -- | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 177.7M | 514.0K | 59.9M | 4.7M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 24.3M | 5.3M | -5.1M | 15.3M | ||
